fda ruling on tirzepatide today Grants a New Indication for Obesity Management Compounded Tirzepatide: FDA Shortage Rules

Dr Fiona Willer, the president of Dietitians Australia, the peak body for dietitians and nutrition professionals, says weight loss medication in Australia must be prescribed alongside a referral to an accredited practising dietitian to ensure nutrition needs are supported

In addition, the follow-up duration of ELIXA was also relatively short (2.1 years), especially when compared with the follow-up duration of 5.4 years in the REWIND trial [60, 62]

Common in obesity and metabolic syndrome

The mean calorie intake was 1,748 kcal/day for the overall sample, 1,700 kcal/day for females, and 1,933 kcal/day for males

The likely next phase is tighter scrutiny of wording, substantiation quality, and the boundary between companion nutrition for drug users and implied pharmacological action